Corning Incorporated

Other

Therapeutiques Substitutives

Didier Letourneur

Pierre Woehl

Jacqueline Jozefonvicz

Patrick Durand

Sylvia Colliec-Jouault

Philippe Caze

Jean-Pierre Themont

Philippe Denis

Charles Mitchel Sorensen, Jr

Christophe Remy

Corinne Sinquin

Jean Millet

Celine Claude Guermeur

Maxime Moreno

Paulo Jorge Marques

Karim Senni

Anne-Marie Fischer

Philippe Roccati

Jean Waku Nsimba

Delphine Machy

J&eacute;r&ocirc;me Leloup

Bernard Pellat

Bruno Gogly

Catherine Blondin

Nsimba J Waku

A method for producing amines by the hydrogenation of nitrile compounds in the presence of a catalyst, notably a method for producing diamines by the continuous hydrogenation of dinitrile compounds in the presence of a Raney-metal catalyst, includes controlling the molar flow of nitrile compounds and the mass flow of catalyst in a hydrogenation piston reactor in order to minimize the occurrence of impurities and deterioration of the catalyst.

Production of amines by hydrogenation of nitrile compounds

A membrane microstructure device is disclosed. The membrane microstructure device includes a first glass, ceramic or glass-ceramic plate defining a first recess, a second glass, ceramic or glass-ceramic plate defining a second recess, and a non-metallic porous membrane sandwiched between the first and second plates. The first plate, second plate and porous membrane are joined together and the porous membrane is arranged to cover the first and second recesses to define a first microchannel between the first plate and the porous membrane and a second microchannel in fluid communication with the first microchannel between the second plate and the porous membrane. A method of manufacturing a membrane microstructure device is also disclosed.

Porous membrane microstructure devices and methods of manufacture

Structured catalysts comprising thick porous inorganic catalyst support coatings disposed on monolithic catalyst support structures, the support coatings having open interconnected porosities of controlled pore size but being characterized by improved durability, physical integrity, and adherence sufficient for use in liquid phase applications under harsh reaction conditions, and methods for making and using them, are disclosed.

Structured catalysts incorporating thick washcoats and method

The invention concerns a flexible vascular prosthesis comprising a synthetic support impregnated with at least a covalently crosslinked dextran and/or at least a functionalised derivative of covalently crosslinked dextran. The invention also concerns a method for preparing said prosthesis.

Vascular prosthesis impregnated with crosslinked dextran

The invention concerns the use of a sulphated polysaccharide capable of being obtained by radical depolymerization of a raw fucan derived from Pheophyceae, said polysaccharide having a molar mass not more than 10,000 g/mol, to obtain a medicine for preventing or treating vascular thrombosis, in particular venous thrombosis, arterial thrombosis and arterial restenosis.

Low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity

Methods and apparatus for treating a gas-liquid feed stream with structured monolithic catalysts of honeycomb configuration wherein the catalysts are configured as a stack of honeycomb sections with offset channels, the resulting channel dislocations between adjacent contacting honeycombs in the stack introducing controlled, limited turbulence and mixing of feed stream portions traversing the channels to significantly increase the catalytic efficiency of the reactor.

Stacked monolith reactor and process

A method is disclosed for maintaining a volumetric gas to liquid ratio in a segmented gas/liquid flow along a reactor of monolithic catalyst beds in series. The present invention includes the steps of: initiating the segmented gas/liquid flow at a first end of the reactor by introducing feed liquid and feed gas both at a predetermined volume and a predetermined flow rate; injecting an additional amount of gas at least once into any of the spaces between catalyst beds; and combining the segments of the segmented gas/liquid flow at a second end of the reactor. The injection of gas is controlled such that the segmented gas/liquid flow can be maintained near or at the Taylor regime.

Flow control in a three-phase monolithic catalyst reactor

The invention concerns the use of fucanes for obtaining medicines for modulating metalloprotease and inhibiting leukocytic elastase. Said medicines help activate collagen synthesis inhibit proliferation of gingival fibroblasts, and activate proliferation of dermal fibroblasts. They are useful in particular for treating periodontal pathologies and dermal lesions.

Use of fucane for regulating the reconstruction of connective tissue

Growing community of inventors

Lyons, France

Didier Letourneur